Comparison of Sacral Erector Spinae Plane Block and Supra-Inguinal Fascia Iliaca Block for Analge… (NCT07081867) | Clinical Trial Compass
CompletedNot Applicable
Comparison of Sacral Erector Spinae Plane Block and Supra-Inguinal Fascia Iliaca Block for Analgesia After Hip Fracture Surgery
Turkey (Türkiye)77 participantsStarted 2025-01-15
Plain-language summary
This study compares the postoperative analgesic effectiveness of Sacral Erector Spinae Plane Block (SESPB) and Supra-Inguinal Fascia Iliaca Block (SIFIB) in patients undergoing hip fracture surgery. Both techniques are regional anesthesia methods aiming to reduce postoperative pain and opioid consumption. The study evaluates pain scores, opioid requirements, mobilization times, and hospital discharge times to determine which block provides more effective pain management in different postoperative periods.
Who can participate
Age range
65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged 65 years and older
* Patients undergoing surgery for hip fractures under spinal anesthesia
* Patients who are oriented and cooperative
* Patients who have signed an informed consent form
Exclusion Criteria:
* Patients with contraindications for spinal anesthesia
* Patients with Alzheimer's disease or dementia, and those who are non-oriented or non-cooperative
* Patients with major organ failure (such as heart, liver, or kidney failure)
* Patients who decline to participate in the study
* Patients classified as American Society of Anesthesiologists (ASA) Physical Status IV or higher
* Patients with pathological fractures or bone metastasis
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Postoperative Pain Scores
Timeframe: At 1 hour, 6 hours, 12 hours, and 24 hours postoperatively.
2
Time to First Postoperative Analgesic Requirement
Timeframe: Up to 48 hours postoperatively.
3
Total Postoperative Opioid Consumption
Timeframe: A week
4
Time to First Mobilization
Timeframe: From the end of surgery until first mobilization, typically within 24 to 48 hours postoperatively
Trial details
NCT IDNCT07081867
SponsorProf. Dr. Cemil Tascıoglu Education and Research Hospital Organization